Skip to content

Clinical study of Ayurvedic interventions on Metabolic Syndrome.

Clinical study of Ayurvedic interventions on metabolic syndrome with special reference to Apathya Nimittaja Prameha- A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052781
Enrollment
40
Registered
2023-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E888- Other specified metabolic disorders

Interventions

None listed

Sponsors

National Institute of Ayurveda Deemed to be University Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: I) Patients willing to participate in clinical trial II) Patients having impaired fasting glucose (Fasting blood glucose 126â??200 mg/dl) along with any 2 or more below mentioned conditions; Abdominal obesity (waist circumference >40 inches in men and >35 inches in women), Hyper - triglyceridaemia (S. triglycerides level 150â??500 mg/dl), Low highdensity lipoprotein (HDL) cholesterol (S.HDL cholesterol

Exclusion criteria

Exclusion criteria: 1) Patients having abdominal obesity (waist circumference 2) Patients having Hyper-triglyceridemia (S. triglycerides level >500 mg/dl) 3) Patients having High density lipoprotein (HDL) cholesterol (S. HDL cholesterol >40 mg/dl for men and >50 mg/dl for women) 4) Patients having Blood pressure (Systolic blood pressure 159 mmHg and/or diastolic blood pressure 99 mmHg) 5) Patients having Impaired fasting glucose (Fasting plasma glucose 200 mg/dl) 6) Pregnant and lactating women 7) Patients with type 1 diabetes mellitus 8) Patients already taking Anti-diabetic, Anti-hypertensive, anti-hyperlipidemic drugs or weight lowering drugs

Design outcomes

Primary

MeasureTime frame
Changes in the Fasting Blood Sugar levelTimepoint: From baseline to 56 days of treatment

Secondary

MeasureTime frame
Changes in the Triglycerides, HDL, waist circumference, Framinghams 10-year cardiac risk score and Change in sign and symptoms of Sthaulya and Prameha.Timepoint: Baseline and 56 days after treatment

Countries

India

Contacts

Public ContactDr Bharat Padhar

National Institute of Ayurveda, Deemed to be University, Jaipur

bcpadhar@gmail.com9638435942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026